Cvs Health (CVS) EV to EBIT (2009 - 2026)

Cvs Health (CVS) has reported EV to EBIT for 18 consecutive years, with 25.19 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EV to EBIT fell 18.3% year-over-year to 25.19; the trailing twelve-month figure through Jun 2026 stood at 14.29 (up 74.37% YoY), and the FY2025 full-year result was 19.41, up 261.34% from the prior year.
• EV to EBIT rose to 25.19 in Q2 2026 per CVS's latest filing, from 17.05 in the prior quarter.
• Across five years, EV to EBIT topped out at 83.64 in Q3 2024 and bottomed at 26.98 in Q3 2022.
• Historically, EV to EBIT has averaged 23.44 across 5 years, with a median of 22.7 in 2022.
• The sharpest annual moves came in 2022 and 2024: EV to EBIT plunged 182.96% in 2022, then soared 317.93% in 2024.
• Over 5 years, EV to EBIT stood at 28.89 in 2022, then decreased by 7.22% to 26.81 in 2023, then dropped by 27.95% to 19.32 in 2024, then jumped by 121.69% to 42.82 in 2025, then tumbled by 41.18% to 25.19 in 2026.
• According to Business Quant data, EV to EBIT over the past three periods registered 25.19, 17.05, and 42.82 for Q2 2026, Q1 2026, and Q4 2025 respectively.